IIN Intricon Corporation

IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced that it will introduce its new wireless nanoLink� product family at the European Union of Hearing Aid Acousticians� (EUHA) 53rd Annual Congress in Leipzig, Germany. Part of the company�s Bodynet� wireless portfolio, nanoLink is a family of products based on proprietary new radio technology and circuitry developed by IntriCon. nanoLink�s advanced capabilities and micro-miniature footprint enable wireless sensing and intra-device communication that�s ideally suited for both the hearing health and medical markets. �We�re very excited to introduce the new nanoLink product group, which is at the forefront of wireless radio technology,� said Mark S. Gorder, IntriCon president and chief executive officer. �A key focus for IntriCon is working directly with our customers and continuing to invest in R&D based on their marketplace needs�and nanoLink is the direct result of that strategy. This product family will not only allow us to develop smaller, more advanced hearing health devices, but it also enables future medical applications including the bio-telemetry of critical diagnostic and therapeutic information. We currently have several experimental bio-telemetry projects under way.� Included in the product line: nanoLink Radio Module� This module combines the high-speed nanoLink 405MHz digital radio integrated circuit (IC) into a package with the Orela digital signal processor (DSP) and a 256kbit EEPROM�memory that stores device critical information. Together they form an ultra compact, low power solution for advance signal processing and wireless audio and data telemetry. nanoLink Programming Adapter�A device that provides the capability to wirelessly program any hearing aid containing an IntriCon DSP amplifier from a Windows PC via the standard USB interface. The system consists of a hearing aid adapter unit and a PC adapter unit. Said Gorder, �By adding comprehensive wire capabilities to our portfolio, nanoLink further enhances the mobility and effectiveness of body-worn devices. Beyond hearing health and medical, we intend to leverage this technology for our professional audio business, which focuses on security and emergency response needs, and hearing protection.� About IntriCon Corporation Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature and micro-miniature body-worn medical and electronics products. The company is focused on three key markets: medical, hearing health, and professional audio and communications. IntriCon has facilities in the United States, Asia and Europe. The company�s common stock trades under the symbol �IIN� on the NASDAQ Stock Market. For more information about IntriCon, visit www.intricon.com. Forward-Looking Statements Statements made in this release and in IntriCon�s other public filings and releases that are not historical facts or that include forward-looking terminology such as �may�, �will�, �believe�, �expect�, �should�, �optimistic� or �continue� or the negative thereof or other variations thereon are �forward-looking statements� within the meaning of the Securities Exchange Act of 1934 as amended. These forward-looking statements include, without limitation, statements concerning the benefits of IntriCon's technology, prospects in the miniature body-worn device arena, future growth and expansion, future financial condition and performance, prospects and the positioning of IntriCon to compete in chosen markets. These forward-looking statements may be affected by known and unknown risks, uncertainties and other factors that are beyond IntriCon�s control, and may cause IntriCon�s actual results, performance or achievements to differ materially from the results, performance and achievements expressed or implied in the forward-looking statements. These risks, uncertainties and factors include, without limitation, possible non-performance of new and developing technology, risks related to the Tibbetts acquisition, including unanticipated liabilities and expenses, the risk that IntriCon may not be able to achieve its long-term strategy, weakening demand for products of the company due to general economic conditions, the volume and timing of orders received by the company, changes in the mix of products sold, competitive pricing pressures, availability of electronic components for the company�s products, ability to create and market products in a timely manner, competition by competitors with more resources than the company, foreign currency risks arising from the company�s foreign operations and other risks detailed from time to time in the company�s filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2007. The company disclaims any intent or obligation to publicly update or revise any forward-looking statements, regardless of whether new information becomes available, future developments occur or otherwise.